Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

Comparison of prognostic nomograms based on different nodal staging systems in patients with resected gastric cancer.

Wang ZX, Qiu MZ, Jiang YM, Zhou ZW, Li GX, Xu RH.

J Cancer. 2017 Mar 12;8(6):950-958. doi: 10.7150/jca.17370. eCollection 2017.

2.

A High Lymph Node Yield is Associated with Prolonged Survival in Elderly Patients Undergoing Curative Gastrectomy for Cancer: A Dutch Population-Based Cohort Study.

Brenkman HJF, Goense L, Brosens LA, Haj Mohammad N, Vleggaar FP, Ruurda JP, van Hillegersberg R.

Ann Surg Oncol. 2017 Aug;24(8):2213-2223. doi: 10.1245/s10434-017-5815-5. Epub 2017 Feb 28.

3.

Prognostic Discrepancy of the 6th and 7th UICC N Classification for Lymph Node Staging in Gastric Cancer Patients after Curative Resection.

Oh SJ, Suh BJ, Park JK, Oh SD, Yu HJ.

Case Rep Oncol. 2017 Jan 17;10(1):57-65. doi: 10.1159/000455189. eCollection 2017 Jan-Apr.

4.

Is postoperative chemoradiotherapy benefit to D2-resected gastric cancer?

Wang X, Jin J.

Transl Gastroenterol Hepatol. 2016 Mar 16;1:7. doi: 10.21037/tgh.2015.12.07. eCollection 2016. No abstract available.

6.

Does a Higher Cutoff Value of Lymph Node Retrieval Substantially Improve Survival in Patients With Advanced Gastric Cancer?-Time to Embrace a New Digit.

Liu YY, Fang WL, Wang F, Hsu JT, Tsai CY, Liu KH, Yeh CN, Chen TC, Wu RC, Chiu CT, Yeh TS.

Oncologist. 2017 Jan;22(1):97-106. doi: 10.1634/theoncologist.2016-0239. Epub 2016 Oct 27.

PMID:
27789777
7.

The association between institution at orchiectomy and outcomes on active surveillance for clinical stage I germ cell tumours.

Nayan M, Jewett MA, Anson-Cartwright L, Bedard PL, Moore M, Chung P, Warde P, Sweet J, O'Malley M, Hamilton RJ.

Can Urol Assoc J. 2016 May-Jun;10(5-6):204-209.

8.

Alternative staging of regional lymph nodes in gastric cancer.

Szczepanik AM, Paszko A, Szura M, Scully-Horner T, Kulig J.

Prz Gastroenterol. 2016;11(3):145-149. Epub 2016 Jul 27. Review.

9.

D2-resected stage IIIc gastric cancer patients benefit from adjuvant chemoradiotherapy.

Peng J, Wei Y, Zhou F, Dai J, Zhong Y, Xie C, Qin Y, Gong J, Xiong B, Zhou Y.

Cancer Med. 2016 Oct;5(10):2773-2780. doi: 10.1002/cam4.873. Epub 2016 Sep 26.

10.

The number of retrieved lymph nodes needed for accurate staging differs based on the presence of preoperative chemoradiation for rectal cancer.

Han J, Noh GT, Yeo SA, Cheong C, Cho MS, Hur H, Min BS, Lee KY, Kim NK.

Medicine (Baltimore). 2016 Sep;95(38):e4891. doi: 10.1097/MD.0000000000004891.

11.

A new predictive model combined of tumor size, lymph nodes count and lymphovascular invasion for survival prognosis in patients with lymph node-negative gastric cancer.

Zhao LY, Chen XL, Wang YG, Xin Y, Zhang WH, Wang YS, Chen XZ, Yang K, Liu K, Xue L, Zhang B, Chen ZX, Chen JP, Zhou ZG, Hu JK.

Oncotarget. 2016 Nov 1;7(44):72300-72310. doi: 10.18632/oncotarget.11035.

12.

Impact on long-term survival of the number of lymph nodes resected in patients with pT1N0 gastric cancer after R0 resection: A multicenter study in China.

Zhao J, Du F, Zhang Y, Kan J, Dong L, Shen G, Zheng F, Chen H, Zhao J, Ji F, Luo Y, Ma F, Wang Z, Xu B.

Medicine (Baltimore). 2016 Aug;95(31):e4420. doi: 10.1097/MD.0000000000004420.

13.

Lymph node yield and tumor location in patients with upper tract urothelial carcinoma undergoing nephroureterectomy affects survival: A U.S. population-based analysis (2004-2012).

Chappidi MR, Kates M, Johnson MH, Hahn NM, Bivalacqua TJ, Pierorazio PM.

Urol Oncol. 2016 Dec;34(12):531.e15-531.e24. doi: 10.1016/j.urolonc.2016.06.013. Epub 2016 Jul 27.

PMID:
27476032
14.

Determining the optimal number of lymph nodes harvested during esophagectomy.

Almhanna K, Weber J, Shridhar R, Hoffe S, Strosberg J, Meredith K.

J Gastrointest Oncol. 2016 Jun;7(3):387-94. doi: 10.21037/jgo.2015.12.02.

15.

Subtotal gastrectomy with conventional D2 lymphadenectomy for carcinoma of the distal gastric portion: A retrospective cohort study on clinical outcomes.

Kavaliauskas P, Maziukas R, Samalavicius NE, Kuliavas J, Lunevicius R.

Ann Med Surg (Lond). 2016 Jan 20;6:36-41. doi: 10.1016/j.amsu.2016.01.023. eCollection 2016 Mar.

16.

Influence of negative lymph node in No 7 on survival of patients with middle thoracic esophageal squamous cell carcinoma.

Zhang J, Heng X, Luo Y, Fu Q, Li Z, Che F, Li B.

Onco Targets Ther. 2016 Mar 30;9:1831-7. doi: 10.2147/OTT.S94236. eCollection 2016.

17.

Systemic therapy of non-colorectal gastrointestinal malignancies in the elderly.

Desai AM, Lichtman SM.

Cancer Biol Med. 2015 Dec;12(4):284-91. doi: 10.7497/j.issn.2095-3941.2015.0078. Review.

18.

Bursectomy and non-bursectomy D2 gastrectomy for advanced gastric cancer, initial experience from a single institution in China.

Zhang WH, Chen XZ, Yang K, Liu K, Chen ZX, Zhang B, Zhou ZG, Hu JK.

World J Surg Oncol. 2015 Dec 8;13:332. doi: 10.1186/s12957-015-0744-x.

19.

Prognostic significance of distal subtotal gastrectomy with standard D2 and extended D2 lymphadenectomy for locally advanced gastric cancer.

Zhang CD, Shen MY, Zhang JK, Ning FL, Zhou BS, Dai DQ.

Sci Rep. 2015 Nov 25;5:17273. doi: 10.1038/srep17273.

20.

Clinical significance of accurate identification of lymph node status in distant metastatic gastric cancer.

Zhou R, Wu Z, Zhang J, Wang H, Su Y, Huang N, Shi M, Bin J, Liao Y, Liao W.

Oncotarget. 2016 Jan 5;7(1):1029-41. doi: 10.18632/oncotarget.6009.

Supplemental Content

Support Center